Trial Profile
A multi-center synchronous phase II clinical study integrated SIB-IMRT + pemetrexed in III non-small cell lung cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Apr 2016
Price :
$35
*
At a glance
- Drugs Pemetrexed (Primary) ; Cis diamminediaquaplatinum
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 18 Feb 2016 Status changed from recruiting to completed.
- 14 Sep 2013 New trial record